Immune system and Malignancy Flashcards
What type of vaccines should be avoided in immunocompromised patients?
live
Examples of live vaccines
Measles, mumps, rubella (MMR combined vaccine)
Rotavirus
Smallpox
Chickenpox
Yellow fever
Nasal flu vaccine
What are immunosuppressants used for?
Suppress the immune system and chronic inflamation.
Examples of anti proliferative drugs?
azathioprine, mercaptopurine, mycophenolate
Examples of calcineurin inhibitors
tacrolimus, ciclosporin
What drugs are used in IBD?
Azathioprine, mercaptopurine, ciclosporin, methotrexate, corticosteroids
Azathioprine- MoA
blocks purine synthesis needed for DNA/RNA/protein synthesis
Azathioprine- side effects
blood disorders (leucopenia, thrombocytopenia, anaemia)
Pancreatitis
hypersensitivity
Nausea- take with food
Azathioprine- monitoring (pre-screening and general)
pre screening- TMPT testing
general - FBC (weekly for 4/8 weeks, then 3 monthly)
Azathioprine- counselling
report signs of blood disorders- unexplained bruising or bleeding and infections
If feeling nauseous then take with food
Azathioprine- interactions
ALLOPURINOL (azathioprine is metabolised by xanthines, allopurinol is a xanthine inhibitor)
- ACEi- increases risk of anaemia
- Trimethoprim- haem toxicity
- warfarin- decreases anticoagulant effect
How to deal with con-current use of azathioprine and allopurinol?
reduce to 1/4 of normal dose
Mycophenolate- MoA
blocks guanosine synthesis (purine) needed for DNA synthesis
Mycophenolate- side effects
blood disorders
hypogammaglobinemia
bronchiectasis, pulmonary fibrosis
GI effects (bleeding)
increases risk of skin cancer
Mycophenolate- counselling
report signs of infection/bleeding
report any new and persistent cough and SOB
avoid excessive exposure to sunlight
Mycophenolate- Cautions
recurrent infection
increased serum iG
persistent respiratory symptoms (cough,SOB)
Serious active GI disease- e.g. Ulcerative Colitis
Mycophenolate- Cautions
recurrent infection, increased serum iG
Mycophenolate- contraception requirements (women)
Women:
2 pregnancy tests before treatment
(8-10 days apart)
effective contraception until 6 weeks after stopping
must be part of the PPP
Mycophenolate- contraception requirements (men)
effective contraception until 90 after stopping
Tacrolimus- MoA
Calcineurin inhibitor (calcineurin activates T cells)
Tacrolimus- S/E
Blood disorders
Cardiomyopathy
nephrotoxicity
photosensitivity
HYPOKALAEMIA, Increased Glucose and urea
Tacrolimus- monitoring
Echo- hypertrophic changes (heart muscle becomes enlarged)
Tacrolimus- counselling
avoid excess UV exposure
blood disorders
report any palpitations, SOB, chest pain (hyperK)
Tacrolimus and ciclosporin- interactions
- Enz inhibitors (toxicity)
- Enz inducers
- Nephrotoxic drugs- aminoglycosides, glycopeptides, Ciclosporin, methotrexate, NSAIDs
- Hyperkalaemia- ACE/ARB, K-sparing, MRA, NSAID, Trimethoprim. Heparin
Tacrolimus- MHRA advice
brand continuity
Tacrolimus/sirolimus- what ethnicity may require an increased dose?
black African or African–Caribbean